<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB
[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
FOR THE YEAR ENDED DECEMBER 31, 1997
OR
[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
Commission File Number: 0-27836
EMBASSY ACQUISITION CORP.
-------------------------
(Name of Small Business Issuer in Its Charter)
FLORIDA 65-0643773
------- ----------
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
1428 Brickell Avenue, Suite 105
Miami, Florida 33131
(305) 374-6700
-------------------------------------------------------------------
(Address of Principal Executive Offices, Zip Code; Telephone Number
Including Area Code)
Securities registered under Section 12(b) of the Exchange Act: None
Securities registered under Section 12(g) of the Exchange Act: Common Stock, par
value $.0001 per share
Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes [X]
No [ ]
Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure will be contained, to
the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. [X]
Issuer's revenues for its most recent fiscal year: $0
The aggregate market value of the voting stock held by non-affiliates computed
by reference to the average bid and ask price of such common equity as of March
25, 1998: 1,760,000 shares of common stock, par value $.0001 per share, at
$8.75 per share, or $15,400,000.
Note: If determining whether a person is an affiliate will involve an
unreasonable effort and expense, the issuer may calculate the aggregate market
value of the common equity held by non-affiliates on the basis of reasonable
assumptions, if the assumptions are stated.
ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS:
Check whether the issuer has filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. Yes [ ] No [ ]
<PAGE> 2
APPLICABLE ONLY TO CORPORATE REGISTRANTS:
Number of shares outstanding of each of the issuer's classes of common equity,
as of March 25, 1998: 2,540,000 shares of common stock, par value $.0001 per
share.
DOCUMENTS INCORPORATED BY REFERENCE:
None.
Transitional Small Business Disclosure Format (check one): Yes [ ] No [X]
<PAGE> 3
EMBASSY ACQUISITION CORP.
FORM 10-KSB
YEAR ENDED DECEMBER 31, 1997
TABLE OF CONTENTS
<TABLE>
<CAPTION>
<S> <C> <C>
PART I ..........................................................................................................1
Item 1. Description of Business.........................................................................1
Item 2. Description of Property.........................................................................7
Item 3. Legal Proceedings...............................................................................8
Item 4. Submission of Matters to a Vote of Security Holders.............................................8
PART II .........................................................................................................9
Item 5. Market for Common Equity and Related Stockholder Matters........................................9
Item 6. Management's Discussion and Analysis or Plan of Operation.......................................9
Item 7. Financial Statements...........................................................................11
Item 8. Changes in And Disagreements With Accountants on
Accounting And Financial Disclosure............................................................11
PART III ........................................................................................................12
Item 9. Directors, Executive Officers, Promoters and Control Persons;
Compliance with Section 16(a) of The Exchange Act..............................................12
Item 10. Executive Compensation.........................................................................16
Item 11. Security Ownership of Certain Beneficial Owners And Management.................................16
Item 12. Certain Relationships and Related Transactions.................................................17
Item 13. Exhibits and Reports on Form 8-K...............................................................17
FINANCIAL STATEMENTS............................................................................................F-1
</TABLE>
<PAGE> 4
PART I
ITEM 1. DESCRIPTION OF BUSINESS
GENERAL
- -------
Embassy Acquisition Corp. (the "Company") was formed in November 1995
to seek to effect a merger, exchange of capital stock, asset acquisition or
other similar business combination (a "Business Combination") with an acquired
business (an "Acquired Business"). In connection with its initial
capitalization, the Company issued 1,160,000 shares of its Common Stock, par
value $.0001 per share (the "Common Stock") to its officers, directors, and
other stockholders for an aggregate sum of $76,078. On April 2, 1996, the
Company's Registration Statement on Form SB-2 (the "Registration Statement") was
declared effective by the U.S. Securities and Exchange Commission (the "SEC").
Pursuant to the Registration Statement, the Company, in its initial public
offering of securities, offered and sold 1,380,000 shares of Common Stock at a
purchase price of $6.00 per share (the "Offering") and received net proceeds of
approximately $7,052,263 after the payment of all expenses of the Offering (the
"Net Proceeds"). In addition, the Company issued Underwriter Options to purchase
120,000 shares of Common Stock. See "Management's Discussion and Analysis or
Plan of Operation."
In May of 1997, the Company entered into a letter of intent (the
"Letter of Intent") with Orthodontix, a Florida corporation ("Orthodontix").
Orthodontix is a newly organized corporation established to provide practice
management services to orthodontic practices. On October 30, 1997, a definitive
agreement (the "Merger Agreement") was reached regarding the merger of
Orthodontix Acquisition Corp., a Florida corporation and wholly-owned subsidiary
of the Company ("Embassy Sub"), with and into Orthodontix (the "Merger"). A
special meeting of the Company's shareholders will be held on April 16, 1998
(the "Special Meeting") at which the Company's shareholders will be asked to
consider and vote upon, among other things, the Merger.
Pursuant to the Merger Agreement, among other things, Embassy Sub will
merge with and into Orthodontix, and Orthodontix will become a wholly-owned
subsidiary of the Company. Upon consummation of the Merger (the "Effective
Date"), (i) the Company will issue an aggregate of approximately 3.5 million
shares of its Common Stock to the owners of all of the issued and outstanding
shares of common stock of Orthodontix, in exchange for the acquisition of
substantially all the assets of 27 orthodontic practices (the "Founding
Practices"), which will constitute approximately 57.9% of the then outstanding
shares of the Company's Common Stock, and (ii) the Company's name will be
changed to "Orthodontix, Inc." In addition, in connection with the Merger, the
Company will grant to certain persons options to acquire approximately 959,944
shares of Common Stock at a purchase price of approximately $8.50 per share,
commencing upon the Effective Date and for periods ranging from three to five
years (collectively, the "Closing Stock Options"). The closing of the Merger is
subject to, among other things, approval of the transaction by the Company's
shareholders and subject to applicable law, the consummation by Orthodontix of
the acquisition of the Founding Practices.
According to information furnished to the Company, for the nine month
period ended
<PAGE> 5
September 30, 1997 (most recent available information), the Founding Practices
on a combined basis generated revenues of $12,053,944 (on an unaudited basis).
Following the consummation of the Offering in April 1996, the Company's
executive officers commenced a search for a prospective Acquired Business.
During the period from April 1996 through May 6, 1997, the date the Company
executed the Letter of Intent, the Company's executive officers evaluated
approximately 75 prospective Acquired Businesses in various fields of endeavor.
In addition to Orthodontix, serious consideration was given to effecting a
Business Combination with two such prospective Acquired Businesses engaged in,
respectively, providing security services and promoting and producing musical
and theatrical live entertainment (collectively, the "Other Two Candidates").
In evaluating each prospective Acquired Business, the Company's
executive officers considered, among other factors, all or a majority of the
following:
* costs associated with effecting the Business Combination;
* equity interest in and opportunity for control of the
prospective Acquired Business;
* growth potential of the prospective Acquired Business and the
industry in which it operates;
* experience and skill of management and availability of
additional necessary personnel of the prospective Acquired
Business;
* capital requirements of the prospective Acquired Business;
* competitive position of the prospective Acquired Business;
* stage of development of the product, process or service of the
prospective Acquired Business;
* degree of current or potential market acceptance of the
product, process or service of the prospective Acquired
Business;
* proprietary features and degree of intellectual property or
other protection of the product, process or service of the
prospective Acquired Business; and
* regulatory environment of the industry in which the
prospective Acquired Business operates.
The Other Two Candidates, which were accorded serious consideration by
the Company's executive officers, were rejected prior to reaching an agreement
in principle for a Business Combination. The primary reasons for rejection of
the Other Two Candidates were as follows:
* Intense competition and uncertainties attendant to an industry
which appears to be becoming increasingly dominated by large
consolidating firms.
* Severe fluctuations in operating results and relative
uncertainty of market taste.
BUSINESS OF ORTHODONTIX
- -----------------------
GENERAL. Immediately subsequent to the consummation of the Merger and
the acquisition of the Founding Practices (the "Practice Acquisitions"),
Orthodontix intends to provide practice management services to the Founding
Practices pursuant to long-term administrative services
2
<PAGE> 6
agreements ("Service Agreements") with separately organized affiliated
professional associations (collectively, the "PA Contractors"). The PA
Contractors will directly employ orthodontists or affiliate with other
separately formed professional associations owned by practicing orthodontists
pursuant to service agreements (the "PA Contractor Employment Agreements")
ranging from terms of two to ten years (the "Practitioner PAs"). In those
practices where the PA Contractors do not directly employ orthodontists, the
Practitioner PAs will directly employ orthodontists. In all cases, Orthodontix
will directly employ all non-orthodontic personnel and, subject to applicable
law, directly own the tangible equipment and other assets used in the practices.
Unless the context otherwise requires, references to (i)"Affiliated Practices"
include the Founding Practices, and any orthodontic practice which enters into a
similar arrangement with Orthodontix whereby Orthodontix provides practice
management services, with orthodontic services provided by the Affiliated
Orthodontists; and (ii) "Affiliated Orthodontists" include orthodontists who
will be directly employed by the PA Contractors or the Practitioner PAs.
THE FOUNDING PRACTICES AND THEIR AFFILIATED ORTHODONTISTS. Orthodontix
will enter into Service Agreements or PA Contractor Employment Agreements with
the Founding Practices or the Affiliated Orthodontists, as the case may be,
which include 28 orthodontists operating 41 offices located in 12 states.
Management of Orthodontix intends to capitalize on the reputations and
relationships of the Founding Practices and their Affiliated Orthodontists to
assist Orthodontix in affiliating with additional orthodontic practices.
Management believes that Orthodontix' management, marketing, recruiting and
growth strategies, as applied to the Founding Practices, will maximize
Orthodontix' revenues.
SERVICES OF ORTHODONTIX. Orthodontix intends to provide practice
management services to the Affiliated Practices. Orthodontix does not practice
orthodontics or dentistry, but generally acquires certain tangible and
intangible assets of an orthodontic practice, employs the non-orthodontic
employees, and causes the PA Contractors to enter into Service Agreements or PA
Contractor Employment Agreements with the Affiliated Practices or the Affiliated
Orthodontists, as the case may be. Where state law allows and upon request by an
Affiliated Practice, Orthodontix leases equipment or office space to the
Affiliated Practices. Each Affiliated Practice, in its sole discretion,
determines the fees to be charged for services provided to patients based upon
market conditions in the service area and other factors deemed appropriate by
the Affiliated Practice.
Orthodontix will generate revenues by providing practice management
services to the Affiliated Practices, including billing and collections, cash
management, purchasing, inventory management, payroll processing, employee
benefits administration, advertising and marketing, financial reporting and
analysis, productivity reporting and analysis.
THE ORTHODONTIC INDUSTRY. Orthodontics historically has been one of the
more profitable specialties in dentistry. According to the 1995 Journal of
Clinical Orthodontists Orthodontic Practice Study (the "1995 JCO Study"), in
1994, orthodontists in the United States conducted examinations of nearly 2.5
million potential new patients and initiated treatment for approximately 1.5
million patients. The typical orthodontist initiated treatment for approximately
170 patients in 1994 and maintained approximately 380 active cases.
The primary target market for orthodontic treatment is children ages 8
to 18. In 1994,
3
<PAGE> 7
approximately 80%, or 1.2 million, of all patients treated were children. The
U.S. Census Bureau estimates that as of July 1, 1996, there were approximately
37.6 million children and adolescents between the ages of 10 and 19. Orthodontix
believes that as many as 50% of these children and adolescents could benefit
from orthodontic treatment, presenting an attractive opportunity for
Orthodontix. In addition to the traditional juvenile market, the adult market
has been a rapidly growing market for orthodontic services. Orthodontix believes
the market for adults has grown rapidly over the last 15 years as a result of
several factors. Adults today are more conscious about their appearance, which
may be improved by orthodontic treatment they may not have received as children.
Moreover, many adults today are more willing to undergo orthodontic treatment in
light of the development of new orthodontic materials and techniques that allow
the orthodontist largely to conceal the bands and brackets used during treatment
because they match the color of the teeth. Based on statistics obtained from the
1995 JCO Study, management believes that the adult market for orthodontic
services remains untapped, as the number of adults who need or want orthodontic
treatment substantially exceeds the number of patients currently seeking
treatment. In 1994, standard case fees averaged approximately $3,500 for
children and $3,800 for adults. According to the 1997 JCO Practice Study (the
"1997 JCO Study"), on an individual practice basis, median annual revenues were
$518,800 and median operating income was $224,000 in 1996. Median overhead as a
percentage of revenues was 55%. Median down payments were equal to approximately
25% of the total treatment cost. Median case starts and active treatment cases,
according to the 1997 JCO Study, were 180 and 400 per practice in 1996,
respectively.
Currently, there are approximately 9,000 practicing orthodontists in
the United States. The industry is highly fragmented, with approximately 90% of
the practicing orthodontists acting as sole practitioners and the balance
practicing in multiple-doctor practices (generally two orthodontists) or in
groups affiliated with competitors of Orthodontix. The training and
qualification of an orthodontist is rigorous.
OPERATIONS: PAYMENT PLAN; CASE FEES. At the initial orthodontic
treatment, the patient signs a contract outlining the terms of the treatment,
including the anticipated length of treatment and the total fees. Each
Affiliated Orthodontist determines the appropriate fee to charge for services to
patients based upon market conditions in the area served by that Affiliated
Orthodontist. Generally, the amount of fees charged by the Affiliated
Orthodontists are independent of the patient's source of payment. The number of
required monthly payments is estimated at the beginning of the case and
generally corresponds to the anticipated number of months of treatment.
Depending on the patient's credit history, the down payment will range from a
substantial down payment to no down payment. Patients are typically required to
pay equal monthly installments although each Affiliated Practice will offer a
payment plan tailored to its market and patients.
If the treatment period exceeds the period originally estimated by the
orthodontist, the patient and the Affiliated Orthodontist will determine whether
payment for additional treatment will be required. If the treatment is completed
prior to the scheduled completion date, the patient is required to pay the
remaining balance of the contract. If a patient terminates the treatment prior
to the completion of the treatment period, the patient is required to pay the
balance due for services rendered to date. Other payment plans with lower
monthly payments are available for patients who have insurance coverage for the
treatment. Payments for patients with insurance may be lower,
4
<PAGE> 8
depending upon the amount of the fee paid on behalf of the patient by insurance
policies. For patients with insurance coverage, the portion of the fee not
covered by insurance is paid by the patient and is not generally waived or
discounted by the Affiliated Practice.
PURCHASING. Orthodontix intends to coordinates quantity discounts of
equipment, office furniture, inventory and supplies for the Affiliated Practices
in order to reduce per unit costs. In addition, Orthodontix intends to negotiate
arrangements with other suppliers, such as casualty insurance carriers, that
should provide cost savings to the Affiliated Practices.
LOCATIONS. Upon consummation of the Practice Acquisitions, Orthodontix
will provide management services to the following locations:
<TABLE>
<CAPTION>
NUMBER OF NUMBER OF NUMBER OF
STATE ORTHODONTISTS (1) OFFICES CITIES
----- ----------------- ------------- ------
<S> <C> <C> <C>
California 1 1 1
Florida 14 21 19
Georgia 1 1 1
Illinois 4 6 5
Kentucky 1 2 2
Louisiana 1 1 1
Maryland 1 1 1
Massachusetts 1 2 2
Ohio 1 2 2
Pennsylvania 1 1 1
Texas 1 1 1
Virginia 1 2 2
--------- -------- --------- ---------
TOTAL 28 41 38
</TABLE>
- ----------------
(1) The Founding Practices include an aggregate of 28 Affiliated Orthodontists,
operating in 12 states.
AFFILIATED ORTHODONTIST, PA CONTRACTOR AND OTHER CONTRACTUAL
RELATIONSHIPS. Orthodontix will contract with the PA Contractors who employ
Affiliated Orthodontists pursuant to PA Contractor Employment Agreements or
affiliate with Affiliated Orthodontists pursuant to Service Agreements to
provide orthodontic services. The PA Contractor Employment Agreements and
Service Agreements typically have terms ranging from two to ten years. The
Affiliated Orthodontists generally receive a percentage of the gross revenue
generated at the Affiliated Practice as well as a percentage of the Net
Operating Income derived from the Affiliated Practice. The Affiliated
Orthodontists are required to hold a valid license to practice orthodontics in
the jurisdiction in which the Affiliated Orthodontist practices. All of the
Affiliated Orthodontists have agreed, for a period of one to two years after the
termination of employment or affiliation, not to compete with Orthodontix or the
PA Contractor within a defined geographic area and not to solicit Affiliated
Orthodontists, other employees or patients of the Affiliated Practices.
Orthodontix will enter into Administrative Services Agreements with the
PA Contractors. Under the Administrative Services Agreements, Orthodontix will
have control over all non-orthodontic functions of the PA Contractors, including
all administrative, management, billing and
5
<PAGE> 9
support functions. The PA Contractors will pay Orthodontix a management fee for
its services. In certain states, the fee is equal to a percentage of the gross
revenue generated by the underlying Affiliated Practices contracting with the PA
Contractors as well as a percentage of the Net Operating Income of such
underlying Affiliated Practices. In other states, the management fee consists of
a flat base fee, which is determined on an annual basis. Each of the
Administrative Services Agreements has a term of 40 years and is subject to
renegotiation at the end of such term.
GOVERNMENT REGULATION. The business of Orthodontix is subject to a
variety of governmental and regulatory requirements relating to healthcare
matters as well as laws and regulations which relate to business corporations in
general. In general, regulation of healthcare companies is increasing. Every
state imposes licensing requirements on individual orthodontists and on
facilities operated by and services rendered by orthodontists. In addition,
federal and state laws regulate health maintenance organizations and other
managed care organizations for which orthodontists may be providers. In
connection with the entry into new markets, Orthodontix, the Affiliated
Practices and the Affiliated Orthodontists may become subject to compliance with
additional regulations.
The operations of the Affiliated Practices must meet federal, state and
local regulatory standards in the areas of safety and health. Historically,
compliance with those standards has not had any material adverse effect on the
operations of the Founding Practices. Based on its familiarity with the
historical operations of the Founding Practices and the activities of
Orthodontix' Affiliated Orthodontists, Orthodontix believes that the Affiliated
Practices are in compliance in all material respects with all applicable
federal, state and local laws and regulations relating to safety and health.
STATE LEGISLATION. The laws of several states prohibit orthodontists
from splitting fees with non-orthodontists. Furthermore, many states prohibit
non-orthodontic entities from practicing orthodontics, employing orthodontists,
or in some circumstances, employing orthodontic assistants. The laws of some
states prohibit advertising orthodontic services under a trade or corporate name
and require that all advertising be in the name of the orthodontist. A number of
states also regulate the content of advertisement of orthodontic services and
the use of promotional gift items. A number of states limit the ability of a
non-licensed dentist or non-orthodontist to own equipment or offices used in an
orthodontic practice. Some of these states allow leasing of equipment and office
space to an orthodontic practice, under a bona-fide lease, if the equipment and
office remain in the complete care and custody of the orthodontist. Orthodontix
believes, based on its familiarity with the historical operations of the
Founding Practices, the intended activities of Orthodontix' Affiliated
Orthodontists and applicable regulations, that Orthodontix' activities do not
constitute the prohibited practices contemplated by these statutes and
regulations. There can be no assurance, however, that future interpretations of
such laws, or the enactment of more stringent laws, will not require structural
and organizational modifications of Orthodontix's initial relationships with its
Affiliated Orthodontists or the operation of the Affiliated Practices. In
addition, statutes in some states could restrict expansion of Orthodontix'
operations in those jurisdictions.
REGULATORY COMPLIANCE. Orthodontix may be required to modify its
agreements, operations and marketing strategies from time to time in response to
changes in the business and regulatory environment. Orthodontix intends to
structure all of its agreements, operations and marketing in
6
<PAGE> 10
accordance with applicable law, although there can be no assurance that its
arrangements will not be successfully challenged or that required changes may
not materially affect the Orthodontix' business, financial condition and results
of operations.
COMPETITION. Orthodontix anticipates facing substantial competition
from other entities as Orthodontix seeks to affiliate with additional
orthodontic practices. Orthodontix is aware of several practice management
companies that are focused in the area of orthodontics. Additional entities may
enter this market and compete with Orthodontix. Certain of these competitors
have greater financial or other resources than Orthodontix.
The business of providing orthodontic services is highly competitive in
each market in which the Affiliated Practices and other practices operate.
Founding Practices compete with orthodontists who maintain single offices or
operate a single satellite office, as well as with orthodontists that maintain
group practices or operate in multiple offices. Founding Practices also compete
with general dentists and pedodontists who provide certain orthodontic services,
some of whom have more established practices. The provision of orthodontic
services by such dentists and pedodontists has increased in recent years. There
can be no assurance that Orthodontix or the Affiliated Practices will be able to
compete effectively within their markets.
EMPLOYEES. Orthodontix anticipates that it will have approximately 220
employees subsequent to the closing of the Practice Acquisitions.
INTELLECTUAL PROPERTY. Orthodontix has not applied for or obtained any
registrations of its trademarks or service marks. Orthodontix is aware of one
other orthodontic practice management company in the United States that uses, in
part the name "Orthodontix." There can be no assurances that actions taken by
the Orthodontix will be adequate to protect Orthodontix' intellectual property
rights, if any.
CORPORATE LIABILITY AND INSURANCE. The Affiliated Practices provide
orthodontic services to the public and are exposed to the risk of professional
liability and other claims. Such claims, if successful, could result in
substantial damage awards to the claimants that may exceed the limits of any
applicable insurance coverage. Although Orthodontix does not control the
practice of orthodontics by the Affiliated Practices, it could be asserted that
Orthodontix should be held liable for malpractice of an Affiliated Orthodontist.
Orthodontix will maintain general liability insurance for itself and on
behalf of the Affiliated Practices and it is anticipated that, where permitted
by applicable law and insurers, Orthodontix will be named as an additional
insured under the policies of the Affiliated Practices. There can be no
assurance that any claims against Orthodontix or any of the Affiliated Practices
will not be successful, or if successful, will not exceed the limits of
available insurance coverage or that such coverage will continue to be available
at acceptable rates.
ITEM 2. DESCRIPTION OF PROPERTY
The Company currently maintains, at no cost to the Company, its
executive offices in
7
<PAGE> 11
approximately 500 square feet of office space located at 1428 Brickell Avenue,
Suite 105, Miami, Florida 33131. This office space is leased by the Company from
Ivenco, Inc., a firm of which Ernest Halpryn, the father of Glenn L. Halpryn, is
an officer. Upon consummation of the Merger, the Company will no longer occupy
this space.
Orthodontix currently subleases, on a month to month basis,
approximately 1,200 square feet of office space in Coral Gables, Florida from
Guilford & Associates, P.A., a firm wholly owned by F.W. Mort Guilford, the
President and Chief Operating Officer of Orthodontix, for a monthly rental
amount of approximately $1,000. In addition to the monthly rental amount,
Orthodontix is liable to pay to Guilford & Associates, P.A. Orthodontix's
pro-rata share of office expenses. Upon consummation of the Merger, it is
presently anticipated that Orthodontix will rent approximately 3,000 square feet
of office space in the Miami-Dade County, Florida area. In addition, upon
consummation of the Practice Acquisitions, Orthodontix will become obligated
under 41 separate lease agreements relating to office space of the Founding
Practices.
ITEM 3. LEGAL PROCEEDINGS
The Company is not presently a party to any material litigation, nor,
to the knowledge of management, is any such litigation presently threatened.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
During the fourth quarter of the fiscal year covered by this Report, no
matters were submitted to a vote of security holders of the Company, through the
solicitation of proxies or otherwise.
[This Space Intentionally Left Blank]
8
<PAGE> 12
PART II
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
The Company's Common Stock, par value $.0001 per share, has been quoted
in the over-the-counter market under the symbol "MBCA" since April 2, 1996. The
following table shows the reported low bid and high bid quotations for the
Company's Common Stock for the periods indicated below. The high and low bid
prices for the periods indicated are interdealer prices, without retail mark-up,
mark-down or commissions and may not necessarily represent actual transactions.
These quotations have been obtained from the OTC Bulletin Board.
<TABLE>
<CAPTION>
Low Bid High Bid
(Per Share) (Per Share)
----------- -----------
<S> <C> <C>
1996
April 2 through June 30.................................$6.00 $6.25
Third Quarter...........................................$6.00 $6.25
Fourth Quarter..........................................$6.00 $6.25
1997
First Quarter...........................................$6.00 $8.375
Second Quarter..........................................$7.125 $9.25
Third Quarter...........................................$8.00 $8.00
Fourth Quarter..........................................$5.25 $8.75
1998
January 1 through March 25, 1998........................$8.00 $8.75
</TABLE>
The approximate number of holders of record of the Company's Common
Stock, as of March 25, 1998, amounts to 46, inclusive of those brokerage firms
and/or clearing houses holding the Company's shares of Common Stock for their
clientele (with each such brokerage house and/or clearing house being considered
as one holder).
The Company has not paid or declared any dividends upon its Common
Stock since its inception and, by reason of its present financial status and its
contemplated financial requirements, does not contemplate or anticipate paying
any dividends upon its Common Stock in the foreseeable future.
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
THE FOLLOWING DISCUSSION OF THE RESULTS OF OPERATIONS AND THE FINANCIAL
CONDITION OF THE COMPANY SHOULD BE READ IN CONJUNCTION WITH THE COMPANY'S
FINANCIAL STATEMENTS AND NOTES THERETO INCLUDED ELSEWHERE IN THIS REPORT.
The Company was formed in November 1995 to seek to effect a Business
Combination with an Acquired Business. In connection with its initial
capitalization, the Company issued 1,160,000 shares of its Common Stock to its
officers, directors, and other stockholders for an aggregate sum of $76,078. On
April 2, 1996, the Company's Registration Statement was declared effective by
the
9
<PAGE> 13
Commission. Pursuant to the Registration Statement, the Company, in its initial
public offering of securities, offered and sold 1,380,000 shares of Common
Stock, par value $.0001 per share, at a purchase price of $6.00 per share (the
"Offering") and received net proceeds of approximately $7,052,263 after the
payment of all expenses of the Offering (the "Net Proceeds"). In addition, the
Company issued Underwriter Options to purchase 120,000 shares of Common Stock.
The Offering was a "blank check" offering.
The Company's objective is to seek to effect a Business Combination
with an Acquired Business, which the Company believes has growth potential. In
May 1997, the Company entered into the Letter of Intent with Orthodontix
regarding a possible Business Combination. On October 30, 1997, the Company and
Orthodontix entered into the Merger Agreement providing for the Merger of
Embassy Sub with and into Orthodontix. Pursuant to the Merger Agreement, upon
the closing of the Merger, Orthodontix will become a wholly-owned subsidiary of
the Company in exchange for approximately 3.5 million shares of Common Stock of
the Company, representing approximately 57.9% of the Common Stock outstanding
after giving effect to the Merger, and without giving effect to the exercise of
the Closing Stock Options and the Underwriter Options.
LIQUIDITY AND CAPITAL RESOURCES/PLAN OF OPERATION.
As of December 31, 1997 and December 31, 1996, the Company had cash of
$547,939 and $763,965, respectively, and restricted cash and cash equivalents of
$6,878,156 and $6,566,206, respectively. As of December 31, 1997 and December
31, 1996, the Company had total liabilities of $88,850 and $79,963,
respectively, common stock subject to redemption of $7,378,467 and $7,260,022,
respectively, and total shareholders' equity of $0 and $0, respectively. Ninety
percent of the Net Proceeds ($6,346,800) (the "Escrow Fund") was delivered to
Fiduciary Trust International of the South, as Escrow Agent, to be held in
escrow by such firm, until the earlier of (i) written notification by the
Company of its need for all or substantially all of the Escrow Fund for the
purpose of facilitating a Business Combination; or (ii) the exercise by certain
stockholders of the Redemption Offer. As of December 31, 1997, there was
$6,878,156 in the Escrow Fund, which was invested in United States
government-backed short-term securities. The Escrow Fund will be released to the
Company upon consummation of the Merger on the Effective Date.
Other than the Escrow Fund, the Company, as of December 31, 1997, had
$547,939 in cash and cash equivalents, all of which was received from the
Offering (other than interest income earned thereon) (the "Operating Funds").
The Company believes the Operating Funds will be sufficient for its cash
requirements for the next twelve months.
The expenses required to select and evaluate an Acquired Business
candidate (including conducting a due diligence review) and to structure and
consummate a Business Combination (including the negotiation of relevant
agreements and the preparation of requisite documents for filing pursuant to
applicable securities laws and state corporation laws) cannot be presently
ascertained with any degree of certainty. For the years ended December 31, 1997
and 1996, the Company
10
<PAGE> 14
incurred $164,382 and $44,058, respectively, of operating expenses, which
primarily consisted of professional expenses and generated $343,844 and
$243,743, respectively, of interest income.
YEAR 2000 COMPLIANCE
The Commission has issued Staff Legal Bulletin No. 5 (CF/IM) stating
that public operating companies should consider whether they will suffer any
anticipated costs, problems or uncertainties as a result of the "Year 2000"
issue, which affects existing computer programs that use only two digits to
identify a year in the date field. The Company anticipates that its business
operations will electronically interact with third parties very minimally, and
the issues raised by Staff Legal Bulletin No. 5 are not applicable in any
material way to its contemplated business or operations. Additionally, the
Company intends that any computer systems that it will purchase or lease will
have already addressed the "Year 2000" issue.
ITEM 7. FINANCIAL STATEMENTS
The financial statements included herein, commencing at page F-1, have
been prepared in accordance with the requirements of Regulation S-B and
supplementary financial information included herein, if any, has been prepared
in accordance with Item 310(a) of Regulation S-B.
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
There are not and have not been any disagreements between the Company
and its accountants on any matter of accounting principles, practices or
financial statement disclosure.
[THIS SPACE INTENTIONALLY LEFT BLANK]
11
<PAGE> 15
PART III
ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT
A. IDENTIFICATION OF DIRECTORS AND EXECUTIVE OFFICERS.
The current directors and executive officers of the Company
are as follows:
NAME AGE TITLE
- ---- --- -----
Glenn L. Halpryn 37 President, Director
Craig A. Brumfield 46 Vice President, Treasurer, Director
Ronald M. Stein 37 Vice President, Secretary, Director
Stephen J. Dresnick, M.D. 47 Director
Andrew Marshak 29 Director
GLENN L. HALPRYN has been the President and a member of the Board of
Directors of the Company since its inception. Since 1985, Mr. Halpryn has been
engaged in real estate investment and development activities, including the
management, finance and leasing of commercial real estate. Since April 1988, Mr.
Halpryn has been Vice Chairman of Central Bank, a Florida state-chartered bank.
Since June 1987, Mr. Halpryn has been the President of and beneficial holder of
stock of United Security Corporation, a broker-dealer registered with the NASD.
From June 1992 through May 1994, Mr. Halpryn served as the Vice President,
Secretary-Treasurer of Frost Hanna Halpryn Capital Group, Inc., a "blank check"
company whose business combination was effected in May 1994 with Sterling
Healthcare Group, Inc. (the FHH-Sterling Transaction"). From June 1995 through
October 1996, Mr. Halpryn served as a member of the Board of Directors of
Sterling Healthcare Group, Inc.
CRAIG A. BRUMFIELD has been the Vice President, Treasurer and a member
of the Board of Directors of the Company since its inception. Since April 1995,
Mr. Brumfield has been President and Chief Executive Officer of Pinecrest
Capital, Inc., a private investment firm that initiates structures and
negotiates acquisitions and provides advisory and consulting services to middle
market companies in diverse industries. From October 1984 through March 1995,
Mr. Brumfield was an executive officer of Trivest, Inc. ("Trivest"), a sponsor
of middle market corporate acquisitions. Mr. Brumfield has served as a member of
the Board of Directors of three public companies; Atlantis Plastics, Inc. (May
1991 through March 1995), Loewenstein Furniture Group, Inc. (December 1990
through December 1994) and WinsLoew Furniture, Inc. (December 1994 through March
1995). Prior to joining Trivest, Mr. Brumfield was a Senior Manager with KPMG
Peat Marwick.
RONALD M. STEIN has been the Vice President, Secretary and a member of
the Board of Directors of the Company since its inception. Since October 1992,
Mr. Stein has been a vice president and account executive with First Equity
Corporation of Florida, a broker-dealer registered with the NASD. From April
1988 through October 1992, Mr. Stein was an associate vice president and
accountant executive with Prudential Securities, a broker-dealer registered with
the NASD.
12
<PAGE> 16
STEPHEN J. DRESNICK, M.D. has been a member of the Board of Directors
of the Company since its inception. Dr. Dresnick has served as President, Chief
Executive Officer and Chairman of the Board of Directors of Sterling Healthcare
Group, Inc. and its predecessor corporations since 1987. Dr. Dresnick currently
serves as President, Chief Executive Officer, and a director of FPA Medical
Management, Inc., the parent corporation of Sterling Healthcare Group, Inc. Dr.
Dresnick is a Diplomate of the National Board of Medical Examiners and is
certified by the American Board of Emergency Medicine. Dr. Dresnick is licensed
to practice medicine in 12 states. Dr. Dresnick currently holds an appointment
as Assistant Professor at University if Miami, School of Nursing; is on the
Dean's Advisory Committee at University of Miami, School of Business; is an
Advisory Board Member at the Center for the Advancement of Service Management,
University of Florida, College of Business Administration; is a Clinical
Associate Professor for the Department of Surgery, University of Florida, School
of Medicine; and is a member of the Board of Trustees of Florida International
University.
ANDREW MARSHAK has been a member of the Board of Directors of the
Company since its inception. Since November 1997, Mr. Marshak has been Managing
Director of First Dominion Capital, L.L.P., a merchant banking and asset
management firm. From June 1994 through October 1997, Mr. Marshak was a Vice
President of Indosuez Capital, the North American merchant banking arm of Banque
Indosuez, a Paris-based banking institution. From July 1992 through June 1994,
Mr. Marshak was an associate with Indosuez Capital. From July 1990 through June
1992, Mr. Marshak was a Financial Analyst with Donaldson, Lufkin and Jenrette,
an investment bank.
All directors hold office until the next annual meeting of shareholders
and the election and qualification of their successors. Directors receive no
compensation for serving on the Board of Directors other than reimbursement of
reasonable expenses incurred in attending meetings. Officers are appointed by
the Board of Directors and serve at the discretion of the Board. Messrs.
Halpryn, Stein and Brumfield, the current executive officers of the Company,
intend to devote approximately 20% of their time to the affairs of the Company.
KEY MAN INSURANCE
The Company has obtained a $1,000,000 "key man" policy insuring the
life of Mr. Halpryn. There can be no assurances that such "key man" insurance
will be maintained at reasonable rates, if at all. The loss, incapacity or
unavailability of Mr. Halpryn at the present time or in the foreseeable future,
before a qualified replacement was obtained, could have a material, adverse
effect on the Company's operations.
CONFLICTS OF INTEREST
None of the Company's key personnel are required to commit their full
time to the affairs of the Company and, accordingly, such personnel may have
conflicts of interest in allocating management time among various business
activities. Messrs. Halpryn, Brumfield, Stein, Marshak and Dr. Dresnick (the
"Principal Group Persons") intend to devote approximately 20% of their time to
the affairs of the Company. Certain of these key personnel may in the future
become affiliated with entities, including other "blank check" companies,
engaged in business activities similar to those intended to be conducted by the
Company.
13
<PAGE> 17
In the course of their other business activities, including private
investment activities, the Principal Group Persons may become aware of
investment and business opportunities which may be appropriate for presentation
to the Company as well as the other entities with which they are affiliated.
Such persons may have conflicts of interest in determining to which entity a
particular business opportunity should be presented. In general, officers and
directors of corporations incorporated under the laws of the State of Florida
are required to present certain business opportunities to such corporations.
Accordingly, as a result of multiple business affiliations, the Principal Group
Persons may have similar legal obligations relating to presenting certain
business opportunities to multiple entities. In addition, conflicts of interest
may arise in connection with evaluations of a particular business opportunity by
the Board of Directors with respect to the foregoing criteria. There can be no
assurances that any of the foregoing conflicts will be resolved in favor of the
Company.
In order to minimize potential conflicts of interest which may arise
from multiple corporate affiliations, each of the Principal Group Persons have
agreed that in the event any of the Principal Group Persons believes that a
business combination opportunity would be appropriate to be considered by an
entity other than the Company with which the Principal Group Person is
affiliated (the "Other Entity") so long as this affiliation existed prior to
November 30, 1995, then the Company will be presented with the business
combination opportunity only after the Other Entity has determined not to pursue
the business combination opportunity.
To further minimize potential conflicts of interest, the Company shall
not consider Business Combinations with entities owned or controlled by
officers, directors, greater than 10% shareholders of the Company or any person
who directly or indirectly controls, is controlled by or is under common control
with the Company. The Company may consider Business Combinations with entities
owned or controlled by persons other than those persons described above. There
can be no assurances that any of the foregoing conflicts will be resolved in
favor of the Company.
Pursuant to an agreement among each of the Principal Group Persons and
the Company, such persons will not actively negotiate for or otherwise consent
to the disposition of any portion of their Common Stock as a condition to or in
connection with a Business Combination. Further, the Company shall not borrow
funds to be used directly or indirectly to (i) purchase any shares of the
Company's Common Stock owned by management of the Company; or (ii) make payments
to the Company's promoters, management or their affiliates or associates.
Management of the Company will not (i) actively negotiate for or otherwise
consent to the disposition of any portion of their Common Stock as a condition
to or in connection with a Business Combination; or (ii) cause the Company to
borrow funds to be used directly or indirectly to purchase any shares of the
Company's Common Stock owned by management.
In connection with a Business Combination, the Company shall not cause
any securities of the Company to be sold by any officers, directors, greater
than 10% shareholders or persons who may be deemed promoters of the Company
without affording all shareholders of the Company a similar opportunity.
14
<PAGE> 18
There are currently no plans, proposals, understandings or arrangements
with respect to the sale of additional securities of the Company to any persons
during the period commencing with the closing of this offering and the
identification by the Company of a Business Combination candidate.
The Company shall not loan any of the Company's assets nor any interest
income derived therefrom to any of the Company's officers, directors, greater
than 10% shareholders or any person who directly or indirectly controls, is
controlled by or is under common control with the Company.
EXPERIENCE OF MANAGEMENT
In connection with any future stockholder vote relating to either
approval of a Business Combination or the liquidation of the Company due to the
failure of the Company to effect a Business Combination within 24 or 30 months,
as the case may be, from the date of consummation of this offering, all of the
officers and directors of the Company, who own in the aggregate approximately
30.7% of the Common Stock outstanding as March 25, 1998, agreed to vote their
respective shares of Common Stock in accordance with the vote of the majority of
the other stockholders of the Company with respect thereto to such liquidation.
In addition, all of the present stockholders have, with respect to shares owned
as of the date hereof, agreed to waive their respective rights to participate in
any distribution relating to such a liquidation.
Messrs. Brumfield and Marshak, an executive officer/director and
director, respectively, of the Company have had certain experience relating to
acquisitions of businesses. Other than with respect to Mr. Halpryn's and Dr.
Dresnick's involvement with the FHH-Sterling Transaction, the Company's officers
have no prior experience relating to the identification, evaluation and
acquisition by a blank check company of an Acquired Business. It is anticipated
that the Principal Group Persons are the only persons whose activities will be
material to the operations of the Company pending the Company's identification
and/or consummation of a Business Combination. Further, only Mr. Halpryn has
ever been an officer, director or greater than 10% shareholder in any company
which engaged in a blind pool/blank check offering of its securities.
B. Significant Employees.
----------------------
None.
C. Family Relationships.
---------------------
None.
D. Business Experience.
--------------------
None.
E. Compliance with Section 16(A).
------------------------------
To the Company's knowledge, for the year ended December 31, 1997, and
for the period
15
<PAGE> 19
ended March 20, 1998, no person who was a director, officer or beneficial owner
of more than ten percent of the Company's outstanding Common Stock or any other
person subject to Section 16 of the Securities Exchange Act of 1934 (the
"Exchange Act") failed to file on a timely basis, reports required by Section
16(a) of the Exchange Act.
F. Other: Involvement In Certain Legal Proceedings.
-------------------------------------------------
There have been no events under any bankruptcy act, no criminal
proceedings and no judgments or injunctions material to the evaluation of the
ability and integrity of any executive officer during the past five years.
ITEM 10. EXECUTIVE COMPENSATION
No executive officer has received any cash compensation from the
Company since inception for services rendered. The Company's officers receive no
compensation, including salaries, for serving as officers other than accountable
reimbursement for any reasonable business expenses incurred in connection with
activities on behalf of the Company. There are no agreements, agreements in
principle or understandings with regard to compensation to be paid by the
Company to any officer or director of the Company. The Escrow Fund (including
any interest earned thereon) shall not be used to reimburse the Company's
officers and directors for expenses incurred by such persons on behalf of the
Company. No funds (including any interest earned thereon) will be disbursed from
the Escrow Fund for reimbursement of expenses. Other than the foregoing, there
is no limit on the amount of such reimbursable expenses, and there will be no
review of the reasonableness of such expenses by anyone other than the Board of
Directors, three of five members of which are officers. None of the Company's
executive officers or directors or their respective affiliates will receive any
consulting or finder's fees in connection with a Business Combination. Further,
none of such persons will receive any other payments or assets, tangible or
intangible, unless received by all other stockholders on a proportionate basis.
ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth information as of the date hereof and as
adjusted to reflect the sale of the Shares offered hereby, based on information
obtained from the persons named below, with respect to the beneficial ownership
of shares of Common Stock by (i) each person known by the Company to be the
owner of more than 5% of the outstanding shares of Common Stock; (ii) each
director; and (iii) all officers and directors as a group:
<TABLE>
<CAPTION>
NAME AND ADDRESS AMOUNT AND NATURE OF APPROXIMATE PERCENTAGE
OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP(1) OF CLASS(2)
- ------------------- ----------------------- -----------
<S> <C> <C>
Glenn L. Halpryn (3) 330,000 13.0%
1428 Brickell Avenue, Suite 105
Miami, FL 33131
</TABLE>
16
<PAGE> 20
<TABLE>
<CAPTION>
<S> <C> <C>
Stephen J. Dresnick, M.D.(4) 160,000 6.3%
5835 Blue Lagoon Drive, 4th Floor
Miami, FL 33126
Ronald M. Stein 170,000 6.7%
1428 Brickell Avenue, Suite 105
Miami, FL 33131
Andrew H. Marshak 60,000 2.4%
1428 Brickell Avenue, Suite 105
Miami, FL 33131
Craig A. Brumfield 60,000 2.4%
1428 Brickell Avenue, Suite 105
Miami, FL 33131
ALL OFFICERS AND DIRECTORS 780,000 30.7%
AS A GROUP (5 PERSONS)
</TABLE>
- --------------------------
(1) Unless otherwise noted, all persons named in the table have sole voting and
investment power with respect to all shares of Common Stock beneficially owned
by them. No persons named in the table are acting as nominees for any persons or
are otherwise under the control of any person or group of persons.
(2) Assumes no exercise of the Underwriter Options.
(3) Does not include shares of Common Stock owned by Ernest Halpryn, Glenn L.
Halpryn' s father, of which Glenn L. Halpryn disclaims beneficial ownership.
(4) Represents 160,000 shares held by Kinserd Limited Partnership ("KLP"). Dr.
Dresnick is the sole limited partner of KLP and the sole shareholder, sole
director and an officer of Kinserd, Inc., the general partner of KLP.
Messrs. Halpryn, Stein and Brumfield may be deemed to be "promoters"
and "parents" of the Company, as such terms are defined under the federal
securities laws.
ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
For the year ended December 31, 1997, there were no material
transactions between the Company and any of its officers and/or Directors which
involved $60,000 or more.
ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits.
1. Financial Statements begin on page F-1.
2. Financial Statement Schedules are not required.
3. Exhibits: See Exhibit Index. The Exhibits listed in
the accompanying Exhibit Index are filed or
incorporated by reference as part of this report.
(b) Reports on Form 8-K.
17
<PAGE> 21
1. Current Report on Form 8-K dated October 30, 1997 and
filed with the Commission on November 7, 1997.
18
<PAGE> 22
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the
Registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
EMBASSY ACQUISITION CORP.
Date: March 25, 1998 By: /s/ Glenn L. Halpryn
-------------------------------
Glenn L. Halpryn
In accordance with the Exchange Act, this report has been signed below
by the following persons on behalf of the Registrant in the capacities and on
the dates indicated.
Date: March 25, 1998 By: /s/ Glenn L. Halpryn
------------------------
Glenn L. Halpryn, President, Director
Date: March 25, 1998 By: /s/ Craig A. Brumfield
--------------------------
Craig A. Brumfield, Vice President,
Treasurer, Principal Financial Officer
and Director
Date: March 25, 1998 By: /s/ Ronald M. Stein
-----------------------
Ronald M. Stein, Vice President,
Secretary and Director
Date: March 25, 1998 By: /s/ Andrew H. Marshak
-------------------------
Andrew H. Marshak, Director
Date: March 25, 1998 By: /s/ Stephen J. Dresnick, M.D.
-----------------------------------
Stephen J. Dresnick, M.D., Director
19
<PAGE> 23
FINANCIAL STATEMENTS
TABLE OF CONTENTS
-----------------
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS........................................................F-1
FINANCIAL STATEMENTS
Balance Sheets, as of December 31, 1997 and 1996.................................................F-2
Statements of Operations for the Years Ended December 31, 1997 and 1996
and for the Period from November 30, 1995 (Date of Inception) to
December 31, 1997.......................................................................... F-3
Statements of Changes in Stockholders' Equity for the Years Ended
December 31, 1997 and 1996 and for the Period from
November 30, 1995 (Date of Inception) to December 31, 1997..................................F-4
Statements of Cash Flows for the Years Ended December 31, 1996 and 1997
and for the Period from November 30, 1995 (Date of Inception) to
December 31, 1997...........................................................................F-5
Notes to Financial Statements....................................................................F-6
</TABLE>
<PAGE> 24
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors of
Embassy Acquisition Corp.
We have audited the accompanying balance sheets of Embassy Acquisition Corp. (a
Florida Corporation in the development stage) as of December 31, 1997 and 1996,
and the related statements of operations, changes in stockholders' equity and
cash flows for the years ended December 31, 1997 and 1996 and the related
statements of operations, changes in stockholders' equity and cash flows for the
period from November 30, 1995 (date of inception) to December 31, 1997. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Embassy Acquisition Corp. as of
December 31, 1997 and 1996, and the results of its operations and its cash flows
for the years ended December 31, 1997 and 1996, and the period from November 30,
1995 (date of inception) to December 31, 1997, in conformity with generally
accepted accounting principles.
COOPERS & LYBRAND L.L.P.
Miami, Florida
March 30, 1998
F-1
<PAGE> 25
EMBASSY ACQUISITION CORP.
(A Development Stage Corporation)
BALANCE SHEETS
<TABLE>
<CAPTION>
ASSETS
December 31, 1997 December 31, 1996
------------------ ------------------
<S> <C> <C>
CURRENT ASSETS:
Cash and cash equivalents $ 547,939 $ 763,965
Restricted cash and cash equivalents 6,878,156 6,566,206
Accrued interest receivable -- 1,342
---------- ----------
Total current assets 7,426,095 7,331,513
Deferred tax assets 41,222 8,472
---------- ----------
Total assets $7,467,317 $7,339,985
========== ==========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accrued expenses $ 38,916 $ 3,487
Income taxes payable 49,934 76,476
---------- ----------
Total liabilities 88,850 79,963
COMMON STOCK SUBJECT TO REDEMPTION 7,378,467 7,260,022
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Common stock, $.0001 par value, 100,000,000 shares
authorized, 2,540,000 issued and outstanding at December
31, 1997 and 1996 -- --
Retained earnings accumulated during the development -- --
Total stockholders' equity -- --
---------- ----------
Total liabilities and stockholders' equity $7,467,317 $7,339,985
========== ==========
</TABLE>
See accompanying notes to financial statements
F-2
<PAGE> 26
EMBASSY ACQUISITION CORP.
(A Development Stage Corporation)
STATEMENTS OF OPERATIONS
<TABLE>
<CAPTION>
For the Period from
For the Year Ended November 30, 1995
December 31, (date of inception)
1997 1996 December 31, 1997
----------- ----------- -----------------
<S> <C> <C> <C>
OPERATING REVENUES $ -- $ -- $ --
----------- ----------- -----------
OPERATING EXPENSES:
General and administrative 164,382 44,058 208,440
----------- ----------- -----------
Total operating expenses 164,382 44,058 208,440
----------- ----------- -----------
Loss from operations (164,382) (44,058) (208,440)
----------- ----------- -----------
Other income:
Interest income 343,844 243,743 587,587
----------- ----------- -----------
Other income 343,844 243,743 587,587
----------- ----------- -----------
Income before income tax provision 179,462 199,685 379,147
Income tax provision 61,017 68,004 129,021
----------- ----------- -----------
Net income $ 118,445 $ 131,681 $ 250,126
=========== =========== ===========
Per share data:
Net income per common and common equivalent share:
Basic $0.05 $0.06
===== =====
Diluted $0.05 $0.06
===== =====
Weighted average shares used in computing
net income per common and common
equivalent share:
Basic 2,540,000 2,187,333
========= ===========
Diluted 2,542,923 2,187,333
========= ===========
</TABLE>
See accompanying notes to financial statements
F-3
<PAGE> 27
EMBASSY ACQUISITION CORP.
(A Development Stage Corporation)
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
For the Years Ended December 31, 1997 and 1996
For the Period from November 30, 1995 (date of Inception) to December 31, 1997
<TABLE>
<CAPTION>
Common Stock Additional
------------------------ Paid-in Retained
Shares Amount Capital Earnings Total
---------- ---------- ---------- ----------- ----------
<S> <C> <C> <C> <C> <C>
Issuance of stock to original stockholders 1,160,000 $ 116 $ 75,962 $ -- $ 76,078
---------- ---------- ---------- ---------- ----------
BALANCE, December 31, 1995 1,160,000 116 75,962 -- 76,078
Issuance of stock to Public Stockholders in connection
with initial public offering 1,380,000 -- -- -- --
Net income for the year ended December 31, 1996 -- -- -- 131,681 131,681
Amounts accruing to the benefit of Public Stockholders -- (116) (75,962) (131,681) (207,759)
---------- ---------- ---------- ---------- ----------
BALANCE, December 31, 1996 2,540,000 -- -- -- --
Net income for the year ended December 31, 1997 -- -- -- 118,445 118,445
Amounts accruing to the benefit of Public Stockholders -- -- -- (118,445) (118,445)
---------- ---------- ---------- ---------- ----------
BALANCE, December 31, 1997 2,540,000 $ -- $ -- $ -- $ --
========== ========== ========== ========== ==========
</TABLE>
See accompanying notes to financial statements
F-4
<PAGE> 28
EMBASSY ACQUISITION CORP.
(A Development Stage Corporation)
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
For the Period From
For the Year Ended November 30, 1995
December 31, (date of inception) to
1997 1996 December 31, 1997
-------- -------- -----------------
<S> <C> <C> <C>
Cash flows from operating activities:
Net income $118,445 $131,681 $250,126
Adjustment to reconcile net income to net cash used in
operating activities:
Deferred income taxes (32,750) (8,472) (41,222)
Net interest on restricted cash and cash
equivalents (343,844) (243,743) (587,587)
Changes in certain assets and liabilities:
Accrued interest receivable 1,342 -- 1,342
Accrued expenses 35,429 3,487 38,916
Income taxes payable (26,542) 76,476 49,934
-------- ---------- ----------
Net cash used in operating activities (247,920) (40,571) (288,491)
-------- ---------- ----------
Cash flows from investing activities:
Increase (decrease) in restricted cash and
cash equivalents 31,894 (6,323,805) (6,291,911)
-------- ---------- ----------
Net cash provided by (used in) investing
activities 31,894 (6,323,805) (6,291,911)
-------- ---------- ----------
Cash flows from financing activities:
Net proceeds from issue of common stock -- 7,052,263 7,128,341
-------- ---------- ----------
Net cash provided by financing activities -- 7,052,263 7,128,341
-------- ---------- ----------
Net (decrease) increase in cash and cash equivalents (216,026) 687,887 547,939
Cash and cash equivalents at beginning of period 763,965 76,078 --
-------- ---------- ----------
Cash and cash equivalents at end of period $547,939 $763,965 $547,939
======== ========== ==========
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Income taxes $120,309 $ -- $120,309
======== ========== ==========
</TABLE>
See accompanying notes to financial statements
F-5
<PAGE> 29
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(1) ORGANIZATION:
Embassy Acquisition Corp. (the "Company") was incorporated in the State of
Florida on November 30, 1995 for the purpose of raising capital and to seek to
effect a merger, exchange of capital stock, asset acquisition or other similar
business combination (a "Business Combination") with an operating business,
which the Company believes has significant growth potential. The Company has had
no operations from November 30, 1995, date of inception, to December 31, 1995.
The Company is currently in the development stage. On April 2, 1996, the
Company's Registration Statement (the "Registration Statement") on Form SB-2 was
declared effective by the U.S. Securities and Exchange Commission. Pursuant to
the Registration Statement, the Company, in its initial public offering of
securities, offered and sold 1,380,000 shares of its common stock, $.0001 par
value, at a purchase price of $6 per share (the "Offering"). Proceeds totaled
$7,052,263, which was net of $1,227,737 in underwriting and other expenses (the
"Net Proceeds").
In connection with the Offering, the Company sold to the managing underwriter
(the "Underwriter") and its designees, for total consideration of $10, stock
purchase options ("the "Underwriter Options") to purchase up to 120,000 shares
of the Company's common stock at an exercise price of $7.80 per share. The
Underwriter Options will be exercisable for a period of five years from the
effective date of the Company's Registration Statement. The Company has also
agreed to certain registration rights with respect to the shares underlying the
Underwriter Options.
In accordance with the Offering, 90% of the Net Proceeds therefrom were placed
in an interest bearing escrow account (the "Escrow Fund") subject to the earlier
of (i) written notification by the Company of its need for all or substantially
all of the Escrow Fund for the purpose of implementing a Business Combination,
(ii) the exercise by certain shareholders of the Redemption Offer, as
hereinafter defined, or (iii) the expiration of no more than 30 months from the
date of the Offering.
F-6
<PAGE> 30
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(1) ORGANIZATION (CONTINUED):
Amounts in the Escrow Fund, including interest earned thereon, are prohibited
from being used for any purpose other than a Business Combination, as defined.
Such amounts are included in restricted cash at December 31, 1997 and 1996.
The Company, prior to the consummation of any Business Combination, will submit
such transaction to the Company's stockholders for their approval. In the event,
however, that the holders of 30% or more of the shares sold in the Offering
which are outstanding vote against approval on any Business Combination, the
Company will not consummate such Business Combination. All of the officers and
directors of the Company, who own in aggregate 30.7% of the common stock
outstanding, have agreed to vote their respective shares of common stock in
accordance with the vote of the stockholders of shares issued in the Offering
(the "Public Shareholders") with respect to any such Business Combination.
At the time the Company seeks stockholder approval of any potential Business
Combination, the Company will offer (the "Redemption Offer") to each of the
Public Stockholders the right, for a specified period of time of not less than
20 days, to redeem all, but not a portion of, their shares of common stock at a
per share price equal to the Company's liquidation value on the record date for
determination of stockholders entitled to vote upon the proposal to approve such
Business Combination (the "Record Date") divided by the number of shares held by
all of the Public Stockholders. The Company's liquidation value will be equal to
the Company's book value, as determined by the Company (the "Company's
Liquidation Value"), calculated as of the Record Date. In no event, however,
will the Company's Liquidation Value be less than the Escrow Fund, inclusive of
any net income thereon. If holders of less than 30% of the shares held by the
Public Stockholders elect to have their shares redeemed, the Company may, but
will not be required to, proceed with such Business Combination. If the Company
elects to so proceed, it will redeem shares, based upon the Company's
Liquidation Value, from those Public Stockholders who affirmatively requested
such redemption and who voted against the Business Combination. If the holders
of 30% or more of the shares held by the Public Stockholders vote against
approval of any potential Business Combination, the Company will not proceed
with such Business Combination and will not redeem such shares unless the terms
of the Offering expire. The Escrow Fund will be released to stockholders voting
against a Business Combination only if such proposed Business Combination is
consummated.
F-7
<PAGE> 31
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(1) ORGANIZATION (CONTINUED):
There is no assurance that the Company will be able to successfully effect a
Business Combination. In the event that the Company does not effect a Business
Combination within 24 months (or in certain circumstances 30 months) from the
date of the consummation of the Offering, the Company will submit to the
stockholders a proposal to liquidate the Company. If the proposal is approved by
a majority of the Public Stockholders, the Company will distribute to the Public
Stockholders, in proportion to their respective equity interest in the Company,
an aggregate sum equal to the Company's Liquidation Value.
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
Cash and Cash Equivalents - Cash and cash equivalents are defined as all highly
liquid financial instruments with maturities of 90 days or less at the date of
purchase. The Company maintains its cash and cash equivalents which consist
principally of demand deposits and repurchase agreements with one financial
institution.
Restricted Cash and Cash Equivalents - Ninety percent of the Net Proceeds were
placed in the Escrow Fund, as described above. As of December 31, 1997 and 1996,
there was $6,878,156 and $6,566,206, respectively, in the Escrow Fund which was
invested in United States government-backed securities with maturities of 90
days or less at the date of purchase.
Common Stock Subject to Redemption - In the event that the Company does not
successfully effect a Business Combination within 24 months (or in certain
circumstances 30 months) from the date of the consummation of the Offering, the
Company will submit a proposal to liquidate the Company. If such proposal is
approved, the Company will distribute the Company's Liquidation Value to the
Public Stockholders. Since the Company may be required to refund all available
equity to the Public Shareholders, such amounts have been classified in the
accompanying balance sheet as common stock subject to redemption. Periodic
changes in the Liquidation Value are reflected as adjustments to stockholders'
equity.
F-8
<PAGE> 32
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED):
Fair Value of Financial Instruments - The carrying amount of cash and cash
equivalents, restricted cash and cash equivalents and accrued expenses
approximate fair value due to the short maturities of these items.
Use of Estimates - The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of income and expenses during the reporting
period. Actual results could differ from those estimates.
Earnings Per Share - During 1997, the Company adopted Statement of Financial
Accounting Standards ("SFAS") No. 128, "Earnings Per Share" and has restated all
years presented in accordance therewith. SFAS No. 128 requires a dual
presentation of basic and diluted earnings per share ("EPS") on the face of the
statement of operations. Basic EPS is computed by dividing net income available
to common stockholders by the weighted-average number of common shares for the
period. Diluted EPS reflects the potential dilution that could occur if
securities or other contracts to issue common stock were exercised or converted
into common stock or resulted in the issuance of common stock that would then
share in earnings. (See Note 6).
Recent Pronouncements - In September 1997, the Financial Accounting Standards
Board issued SFAS No. 130 which established standards of reporting and display
of comprehensive income and its components. SFAS No. 130 is effective for fiscal
years beginning after December 15, 1997. The Company expects that the
implementation of SFAS No. 130 will not have a material impact on its financial
statements.
(3) COMMON STOCK:
The Company's Articles of Incorporation authorize the issuance of 100,000,000
shares of common stock. The Company's Board of Directors has the power to issue
any or all of the authorized but unissued common stock without stockholder
approval. The Company currently has no commitments to issue any shares of common
stock; however, the Company will, in all likelihood, issue a substantial
F-9
<PAGE> 33
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(3) COMMON STOCK (CONTINUED):
number of additional shares in connection with a Business Combination. To the
extent that additional shares of common stock are issued, dilution of the
interests of the Public Stockholders may occur.
(4) RELATED PARTIES:
None of the Net Proceeds have been nor will be used to pay any compensation to
the Company's officers or directors. In addition, no funds, including interest
earned thereon, have been nor will be disbursed from the Escrow Fund for the
reimbursement of expenses incurred on the Company's behalf by the Company's
officers and directors.
Currently, the officers and directors and the other non-public stockholders own
30.7% and 15.0%, respectively, of the issued and outstanding shares of the
Company's common stock.
(5) INCOME TAXES:
The Company is a C Corporation under the provisions of the Internal Revenue Code
and related state income tax statutes.
The components of the provision for income taxes for the years ended December
31, 1997 and 1996 are as follows:
<TABLE>
<CAPTION>
For the period
from November 30, 1995
(date of inception)
1997 1996 to December 31, 1997
---- ---- ----------------------
<S> <C> <C> <C>
Current Provision:
Federal $79,267 $64,507 $ 143,774
State 14,500 11,969 26,469
------- ------- ----------
93,767 76,476 170,243
------- ------- ----------
Deferred Provision:
Federal (27,963) (7,616) (35,579)
State (4,787) (856) (5,643)
------- ------- ----------
(32,750) (8,472) (41,222)
------- ------- ----------
Total $61,017 $68,004 $ 129,021
======= ======= ==========
</TABLE>
F-10
<PAGE> 34
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(5) INCOME TAXES (CONTINUED):
The following reconciles at the federal statutory rate with the effective rate
for the years ended December 31, 1997 and 1996:
<TABLE>
<CAPTION>
For the period from
November 30, 1995
(date of inception) to
1997 1996 December 31, 1997
---- ---- ----------------------
<S> <C> <C> <C>
Federal statutory rate 34.0% 34.0% 34.0%
State taxes, net of federal effect 3.5 3.7 3.6
Benefit of graduated tax rates (3.5) (3.6) (3.6)
----- ----- ------
Effective tax rate 34.0% 34.1% 34.0%
===== ===== ======
</TABLE>
At December 31, 1997 and 1996, the Company had a deferred tax asset relating to
amortization of organizational and start-up costs.
(6) NET INCOME PER COMMON AND COMMON EQUIVALENT SHARES:
The calculation of basic and diluted net income per share for the years ended
December 31, 1996 and 1997 are as follows:
1997 1996
---- ----
Net income $118,445 $131,681
======== ========
Basic income per share:
Weighted average common
shares outstanding 2,540,000 2,187,333
========= =========
Basic income per share $0.05 $0.06
===== =====
Diluted net income per share:
Weighted average common
shares outstanding 2,540,000 2,187,333
Underwriter warrants 2,923 0(1)
--------- ---------
F-11
<PAGE> 35
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(6) NET INCOME PER COMMON AND COMMON EQUIVALENT SHARES (CONTINUED):
Weighted average common and
potential common shares
outstanding 2,540,000 2,187,333
========= =========
Diluted net income per share $0.05 $0.06
===== =====
(1) Warrants to purchase 120,000 shares of common stock were not included in the
computation of diluted net income per share for 1996 since the warrants exercise
price was greater than the average price of the underlying common shares.
(7) BUSINESS COMBINATION
On May 6, 1997, the Company entered into a letter of intent with Orthodontix,
Inc., a Florida corporation ("Orthodontix"), regarding a business combination of
the Company or a newly formed wholly-owned subsidiary and Orthodontix (the
"Transaction"). The intended principal business activity of Orthodontix is
providing practice management services to orthodontic practices. Orthodontix has
conducted no operations to date other than in connection with its agreements to
acquire certain assets, assume certain liabilities, and provide long-term
management services to certain orthodontic practices (the "Founding Practices")
in exchange for cash and shares of common stock (the "Practice Acquisitions").
As of October 30, 1997, the Company and Orthodontix entered into an Agreement
and Plan of Merger and Reorganization (the "Agreement") regarding the
Transaction. Pursuant to the Agreement, the parties shall engage in the
Transaction, which at the closing of the Transaction (the "Closing") will result
in Orthodontix becoming a wholly owned subsidiary corporation of the Company in
exchange for that number of shares of common stock of the Company (the "Merger
Stock") representing approximately 56% of the Company's outstanding shares of
common stock after giving effect to the Transaction but without giving to any
options or warrants to acquire shares of common stock which are contemplated to
be outstanding at the Closing. The actual number of shares to be issued in
connection with the Transaction is subject, in part, to the average of the
closing bid and ask price, as reported on the OTC Electronic Bulletin Board or
similar quotation board of the Company's shares of common stock for the 15
trading days immediately preceding the date of the Closing (the "Share Value").
F-12
<PAGE> 36
EMBASSY ACQUISITION CORP.
(A DEVELOPMENT STAGE CORPORATION)
NOTES TO FINANCIAL STATEMENTS
(7) BUSINESS COMBINATION (CONTINUED):
Pursuant to the terms of the Agreement, the recipients of 1,300,000 shares of
the Merger Stock (approximately 23% of the Company's outstanding shares of
common stock after giving effect to the Transaction, assuming a share value of
$8.00 per share for the Company's common stock) and the shares of Merger Stock
to be issued in connection with the Practice Acquisitions (approximately 33% of
Embassy's outstanding shares of common stock after giving effect to the
Transaction assuming a share value of $8.00 per share for the Company's common
stock), respectively, have agreed, for a period of 15 months and six months,
respectively, from the date of the Closing, not to make any offer, sale or
disposition of any of the Merger Stock to be issued to them in connection with
the Transaction. The Transaction is contemplated to be tax-free to the Company
and its shareholders.
Based on information received from Orthodontix, at the Closing, Orthodontix
shall provide practice management services to approximately 27 orthodontic
practices, which practices generate gross revenue of approximately $16 million
annually. The Closing is subject to, among other conditions, the closing of the
Transaction by April 1, 1998 (this date has been extended by mutual agreement of
the parties), approval of the Transaction by the shareholders of the Company and
Orthodontix, certain regulatory and third party approvals and consents, and the
closing of the Practice Acquisitions. There can be no assurance that the
proposed Transaction will be consummated on these or any other terms.
Based upon the Average Price per share, as defined, of the common stock of the
Company as of March 26, 1998, at the closing of the Transaction and the Practice
Acquisitions, the Company would be obligated to issue approximately 3.5 million
shares of common stock and expend up to approximately $3.4 million in
consideration for the Transaction. Upon effectiveness of the Transaction, the
Company will change its name to "Orthodontix, Inc.," Stephen J. Dresnick, M.D.,
a member of the Company's Board of Directors, President and Chief Executive
Officer of Sterling Healthcare Group, Inc. and Vice Chairman of the Board of FPA
Medical Management, Inc. and Glenn Halpryn, Chairman of the Company would
continue to be members of the Board of Directors of the Company with Dr.
Dresnick assuming the role of Chairman of the Company. There can be no assurance
that the proposed Transaction will be consummated on these or any other terms.
The Company believes the Transaction will be treated as a capital transaction
equivalent to the issuance of stock by Orthodontix for the Company's net
monetary assets of approximately $7.4 million as of December 31, 1997,
accompanied by a recapitalization of Orthodontix.
Because each of the owners of the Founding Practices is a Promoter of the
Transaction, Securities and Exchange Commission's Staff Accounting Bulletin
("SAB") No. 48, "Transfers of Nonmonetary Assets by Promoters or Shareholders",
each Founding Practice will be deemed a promoter of the merger. Pursuant to SAB
No. 48, the transferred nonmonetary assets and assumed liabilities will be
accounted for at the historical cost basis of the Founding Practices and any
monetary assets assumed and any monetary liabilities included in the Practice
Acquisitions will be recorded at fair value, and cash consideration paid in
excess of net assets transferred, will be reflected as a dividend paid by
Orthodontix.
F-13
<PAGE> 37
EXHIBIT INDEX
EXHIBIT DESCRIPTION
2.1* Agreement and Plan of Merger and Reorganization, dated October 30,
1997, between Registrant and Orthodontix, Inc. ("Orthodontix")
(included as Appendix A to the Proxy Statement-Prospectus which
forms a part of this Registration Statement).
3.1** Articles of Incorporation of Registrant.
3.3** Bylaws of Registrant as amended.
4.1** Form of certificate representing shares of Common Stock of
Registrant.
27+ Financial Data Schedule for the Company as of and for the Year
Ended December 31, 1997.
-----------------------
* Incorporated by reference from the Registrant's Current Report on Form 8-K
dated October 30, 1997 and filed with the Commission on November 7, 1997.
** Incorporated by reference from the Registrant's Registration Statement on
Form SB-2 declared effective by the Securities and Exchange Commission on
April 2, 1996.
+ Filed herewith.
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> DEC-31-1997
<CASH> 547,939
<SECURITIES> 6,878,156
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 7,426,095
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 7,467,317
<CURRENT-LIABILITIES> 88,850
<BONDS> 0
0
0
<COMMON> 0
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 7,467,317
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 164,382
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 179,462
<INCOME-TAX> 61,017
<INCOME-CONTINUING> 118,445
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 118,445
<EPS-PRIMARY> 0.05
<EPS-DILUTED> 0.05
</TABLE>
